MOBOCERTINIB for Bone cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where MOBOCERTINIB was used for Bone cancer.
Most Reported Side Effects for MOBOCERTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 309 | 43.2% | 88 | 133 |
| Death | 160 | 22.4% | 160 | 40 |
| Rash | 106 | 14.8% | 20 | 37 |
| Non-small cell lung cancer | 96 | 13.4% | 43 | 21 |
| Nausea | 85 | 11.9% | 19 | 39 |
| Decreased appetite | 80 | 11.2% | 27 | 36 |
| Lung neoplasm malignant | 74 | 10.4% | 32 | 14 |
| Vomiting | 74 | 10.4% | 29 | 47 |
| Fatigue | 66 | 9.2% | 17 | 32 |
| Asthenia | 56 | 7.8% | 22 | 33 |
| Weight decreased | 54 | 7.6% | 9 | 21 |
| Dry skin | 52 | 7.3% | 7 | 17 |
| Stomatitis | 45 | 6.3% | 8 | 19 |
| Pneumonia | 44 | 6.2% | 20 | 35 |
| Product dose omission issue | 42 | 5.9% | 11 | 24 |
Other Indications for MOBOCERTINIB
Lung neoplasm malignant (291)
Product used for unknown indication (170)
Non-small cell lung cancer (169)
Lung adenocarcinoma (29)
Egfr gene mutation (26)
Non-small cell lung cancer metastatic (14)
Lung carcinoma cell type unspecified stage iv (12)
Lung cancer metastatic (10)
Lung adenocarcinoma stage iv (9)
Non-small cell lung cancer stage iv (9)
Other Drugs Used for Bone cancer
PALBOCICLIB (493)
LENALIDOMIDE (342)
CABOZANTINIB S-MALATE (328)
DENOSUMAB (219)
ENZALUTAMIDE (213)
PAZOPANIB (182)
ERLOTINIB (174)
CAPECITABINE (143)
BEVACIZUMAB (140)
POMALIDOMIDE (114)